|
, "Good Package And Label Act "(FPLA) and Other Applicable laws and regulations. FDCA section 801 authorized the U.S. Food and Drug Administration (FDA) inspection by U.S. Customs into the United States of cosmetics. Inspection prior to entry can also be arriving after the importers and brokers. Importer / broker send to the U.S. Customs Customs Copies of invoices for goods with each declaration submitted to the FDA. U.S. Customs and FDA filing of the declaration to identify the classification of the implementation of laws and regulations need to FDA procedures. After receiving the declaration documents, the initial inspection of imported products is the record for review. Recorded on cosmetics review, will make the following decisions: 1, the batch release; 2, the batch of automatic seizure; 3, by terminal examination or sampling to be tested. For cosmetics, terminal testing basically include the mandatory labeling requirements for labeling test to determine whether the labels of cosmetics or listed with the following: 1, ingredient labeling; 2, disable the ingredients; 3, English labels; 4, does not permit the use of the pigment; 5, precautionary statements regulatory requirements; 6 products Xu Yong meet the requirements of Section 21CFR700.25 interference packaging; 7, other mandatory labeling information (such as manufacturer name and address of the factory , packer or distributor business name and address, name, net content of the publication of contents, etc.). For import inspection of all immigration inspectors can product, multiple batches or a single family of products for terminal inspection or sampling. Sample generally includes the physical collection of product or document summary, FDA regional laboratories for subsequent tests. FDA collected samples whenever the owner or the underwriters will always provide a sample notice. Testing may include pigment analysis, contamination analysis, or chemical contamination of microbiological analysis. But the test also tag or label review Make To determine compliance with laws and regulations on cosmetic labeling requirements or whether the statement with the effectiveness of treatment or medication. Import procedures are as follows: 1, arrived in the port of entry of goods from the date of 5 working days of the importer or agency reporting to the U.S. Customs entry documents; 2, when the FDA received a notification entry, the audit unit of the importer's declaration to determine whether physical examination should be carried out (terminal inspection, sampling); 3, if the decision not to collect samples, FDA, respectively, and the case to the U.S. Customs and importers to send (notice lines can be continued). At this point, the consignment shall be released in the FDA office. It should be noted that, "added Bank may, without examination" does not mean that products meet the requirements, it is only when the FDA said the product will not test entry. If a product is found in future violations of laws and regulations, will depend on the nature of the offense start the appropriate legal measures (such as confiscation, etc.). If you decide to sample, FDA, respectively, and the case to the U.S. Customs and importers to send "sampling notice", the goods must be intact pending further notice, FDA will extract samples of the goods. The decision was based on samples collected: 1, the product of nature; 2, FDA focused on the problem; 3, the product of past history. FDA to obtain a physical sample and send it to FDA regional laboratories for analysis. Meet the requirements if the FDA found samples, were sent to the U.S. Customs and the importer of a "notice of release." If the FDA determined that the sample "a violation of FDCA and the performance of other relevant laws" were to the U.S. Customs and importers of the case and send the "seizure and the hearing notice." Notice details and nature of law and to the case and the importer 10 days to provide evidence of the goods may be permitted. Imports have been detained in the FDA or U.S. Customs must be under the supervision of repair, return lost or destroyed. Hearing the importer as imports of defense articles or provide evidence to enable the goods after the appropriate entry after finishing the only opportunity. If the case and the underwriters, cargo owners, importers or designated representative refused to reply to notice, FDA will be the case and the U.S. Customs and importers to send "into the notice of refusal." The products in question and then back to lose or destroy. If the case and the underwriters, the owner, importer or a designated representative replied, "notice of seizure and hearing", when the importer to provide evidence that the products "meet the requirements" or when the application submitted by finishing products, FDA had the products seizure hearing. If the firm provides a product to meet the requirements of evidence, FDA will collect follow-up sample. Analysis of product or to be decided was released or be refused entry. FDA review of the proposed repair procedures for importers, as the case may be approved or not approved. Once approved, FDA will conduct follow-up inspection / sample collection to determine their eligibility. If the samples pass, the U.S. Customs and importers send "release notices." Send the sample was unsatisfactory, issued "notice of refusal into." FDCA section 8 (C) section requires the applicant to pay the full cost, in addition to update the labels or other seizure of goods to meet the application form (FDA-766 form) the terms of the measures of cost, including FDA officials or employees travel, household and wages. By submitting Form FDA-766, the applicant agrees to pay the full cost of supervision current regulations. We are high quality suppliers, our products such as China Touch Screen Notebook Pc , Dvd Replication Services for oversee buyer. To know more, please visits Dvd R Blank Disc.
Related Articles -
China Touch Screen Notebook Pc, Dvd Replication Services,
| 
